Sun Pharma
Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Number of employees. 24,832 (March 2023) Website. www .drreddys .com. Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] Dr.
Dr. Reddy’s Laboratories commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
1 day ago · Stay up-to-date with the Dr. Reddy's Laboratories Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a prominent stock. Explore the latest information on Dr. Reddy's Laboratories, including: Last traded price 6255.45, Market capitalization: 104026.2, Volume: 1250, Price-to-earnings ratio 18.65, Earnings per share 334.37.
2 days ago · Dr Reddy’s Laboratories makes its biggest acquisition by buying British consumer healthcare giant Haleon's nicotine replacement therapy portfolio, excluding the US business, for approximately ...
2 days ago · The acquisition being made by Dr. Reddy’s Laboratories SA is on an upfront cash consideration of GBP 458 million and additional performance-based contingent cash payments of up to GBP 42 million ...
3 days ago · On Thursday, shares of the Dr Reddy’s Laboratories zoomed up to 2.7 per cent at Rs 6,235.90 a piece on the BSE. The stock rose after the company on Wednesday acquired OTC brand Nicotinell from London based consumer healthcare giant Heleon. The Hyderabad based pharmaceutical giant acquired one of ...
